CD36 serves as a candidate gene for impaired fatty acid metabolism, glucose intolerance, arterial hypertension, atherosclerosis, and numerous cardiovascular diseases [83,87] as well as Alzheimer’s disease [88] and malaria [89,90], and may be imperative in the pathogenesis of human IR syndromes. This evidence concerns the gene CD36 and atherosclerosis.